Treatment of Tall Stature in Boys With Somatostatin Analogue 201-995: Effect on Final Height

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje.1.02087
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BioScientifica

Related search

Long Term Treatment by a Long Acting Somatostatin Analogue (Sms 201–995) in a 4 Months Boy Presenting With Primary Permanent Hyperinsulinism

Pediatric Research
Child HealthPediatricsPerinatology
1988English

Adult Height Outcome in Boys With Idiopathic Short Stature

Pediatric Research
Child HealthPediatricsPerinatology
1988English

Successful Treatment With a Long-Acting Somatostatin Analogue(SMS201-995) in a Patient With Malignant Carcinoid Syndrome.

Japanese Journal of Medicine
1988English

Effect of Aromatase Inhibitor Therapy on Predicted Adult Height in Prepubertal Boys With Idiopathic Short Stature

Al-Azhar Journal of Pharmaceutical Sciences
2015English

Reduction of Pituitary Size by the Somatostatin Analogue SMS 201-995 in a Patient With an Islet Cell Tumour Secreting Growth Hormone Releasing Factor

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1986English

Long-Term Treatment of Acromegaly and Gigantism With Octreotide (SMS 201-995)

Folia Endocrinologica Japonica
1992English

Somatostatin Analogue Treatment of Neuroendocrine Tumours.

Postgraduate Medical Journal
Medicine
1996English

Effect of Growth Hormone Therapy on Height in Children With Idiopathic Short Stature

Archives of Pediatrics & Adolescent Medicine
2002English

Evaluation of Near Final Height in Boys With Constitutional Delay in Growth and Puberty

Endocrine Connections
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy